Evidence map›Paper›PMID 42115646›Full record

ArticleNature communications2026

Structural insights into cobalamin loading and reactivation of human methionine synthase.

Douglas S M Ferreira, Katie McLennan, Calum Diamond, Melanie Vollmar, Wasim Kiyani, D Sean Froese, Jola Kopec, Henry J Bailey, Rod Chalk, Arnaud Baslé and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Douglas S M FerreiraNuffield Department of Clinical Medicine, Centre for Medicines Discovery, University of Oxford, Oxford, UK.
Katie McLennanBiosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0009-0005-3201-5519
Calum DiamondBiosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
Melanie VollmarStructural Genomics Consortium, University of Oxford, Oxford, UK.
Wasim KiyaniStructural Genomics Consortium, University of Oxford, Oxford, UK.
D Sean FroeseStructural Genomics Consortium, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1557-3517
Jola KopecStructural Genomics Consortium, University of Oxford, Oxford, UK.
Henry J BaileyStructural Genomics Consortium, University of Oxford, Oxford, UK.
Rod ChalkNuffield Department of Clinical Medicine, Centre for Medicines Discovery, University of Oxford, Oxford, UK.
Arnaud BasléBiosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
Jonathan M ElkinsNuffield Department of Clinical Medicine, Centre for Medicines Discovery, University of Oxford, Oxford, UK.
Jesse A CokerCenter for Therapeutics Discovery, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-1842-9860
Wyatt W YueNuffield Department of Clinical Medicine, Centre for Medicines Discovery, University of Oxford, Oxford, UK. wyatt.yue@newcastle.ac.uk.ORCID http://orcid.org/0000-0001-6959-6007
Thomas J McCorvieBiosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK. thomas.mccorvie@newcastle.ac.uk.ORCID http://orcid.org/0000-0002-1502-7113

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/R013942/1Wellcome TrustWellcome Trust (Wellcome) 092809/Z/10/ZWellcome Trust (Wellcome) 206161/Z/17/ZWellcome Trust (Wellcome) 218785/Z/19/Z
6 · The paper itself

Abstract

Human methionine synthase (MTR) is an essential enzyme of one carbon metabolism. Consisting of a catalytic N-half and a cobalamin binding C-half, MTR utilises this intricate organometallic cofactor in the methyl transfer from methyltetrahydrofolate to homocysteine producing methionine. Cobalamin loading into MTR, and its subsequent activation, requires methylmalonic aciduria and homocystinuria Type D (MMADHC) protein and methionine synthase reductase (MTRR), respectively. However, the molecular basis of cobalamin binding and activation of human MTR aided by MMADHC and MTRR remains unknown. Here, using cryo-electron microscopy, we determine structures of human MTR in its apo, and cobalamin bound states. Apo MTR adopts a conformation where the two halves of the enzyme act independently with the C-half posed to bind cobalamin. Binding of cobalamin and its activation causes conformational changes in MTR that result in a flexible catalytically active state. AlphaFold predictions, validated by interaction studies, show that MMADHC interacts with the C-half of apo MTR to facilitate cobalamin loading. Unexpectedly we found that MTRR interacts at two distinct sites within the C-half of MTR which may aid in activation. Collectively these findings lay the groundwork to uncover the mechanisms through how MMADHC and MTRR coordinate cobalamin loading and activation of human MTR.

Indexed as

5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseVitamin B 12Cryoelectron MicroscopyEnzyme ActivationFerredoxin-NADP ReductaseHumansIntracellular Signaling Peptides and ProteinsModels, MolecularProtein BindingProtein Conformation5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseFerredoxin-NADP ReductaseIntracellular Signaling Peptides and Proteinsmethionine synthase reductaseMMADHC protein, humanMTR protein, humanVitamin B 12

Identifiers

PMID42115646
PMCPMC13376404

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.